AMZ001

DRUG2 trials

Sponsors

Amzell B.V., Amzell

Conditions

Knee OsteoarthritisOsteoarthritis, Knee

Phase 2

AMZ001 for the Treatment of Knee Osteoarthritis Symptoms

CompletedNCT03691844

AmzellOsteoarthritis, Knee

Start: 2018-10-04End: 2019-07-09Updated: 2020-10-06

Phase 3

A Randomized, Double-Blind, Multi-Center, Placebo-Controlled, Trial to Evaluate the Efficacy and Safety of Once Daily Diclofenac Gel AMZ001 3.06% in the Treatment of Pain and Symptoms of Knee Osteoarthritis

CompletedCTIS2024-517404-11-00

Amzell B.V.Knee Osteoarthritis

Start: 2025-04-30End: 2025-12-10Target: 206Updated: 2025-10-07